SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $973,000 | -38.4% | 19,321 | -26.8% | 0.05% | -44.2% |
Q2 2018 | $1,579,000 | -52.1% | 26,389 | -63.3% | 0.10% | -60.1% |
Q1 2018 | $3,297,000 | -43.5% | 71,989 | -50.8% | 0.24% | -48.1% |
Q4 2017 | $5,834,000 | +22.8% | 146,396 | +23.2% | 0.46% | +15.9% |
Q3 2017 | $4,751,000 | -7.3% | 118,782 | -0.1% | 0.40% | -16.1% |
Q2 2017 | $5,125,000 | -14.2% | 118,907 | -37.7% | 0.47% | -21.3% |
Q1 2017 | $5,976,000 | -66.7% | 190,938 | -73.2% | 0.60% | -2.8% |
Q4 2016 | $17,968,000 | -10.0% | 711,599 | -11.8% | 0.62% | -5.7% |
Q3 2016 | $19,958,000 | +13.8% | 807,049 | -6.3% | 0.65% | +2.3% |
Q2 2016 | $17,538,000 | +195.0% | 860,969 | +120.9% | 0.64% | +195.8% |
Q1 2016 | $5,945,000 | – | 389,840 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |